Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic Syndromes × Prednisone × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 20 Lymphoma, Large B-Cell, Diffuse 13 Burkitt Lymphoma 12 Lymphoma, Follicular 9 Lymphoma 9 Lymphoma, Non-Hodgkin 7 Prostatic Neoplasms, Castration-Resistant 5 Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, B-Cell, Marginal Zone 3 Hodgkin Disease 3 Waldenstrom Macroglobulinemia 2 Recurrence 2 Myasthenia Gravis 2 Hematologic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Vasculitis, Central Nervous System 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stiff-Person Syndrome 1 Skin Neoplasms 1 Rasmussen subacute encephalitis 1 Prostate Cancer Metastatic 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Plasmablastic Lymphoma 1 Ovarian Neoplasms 1 Opsoclonus-Myoclonus Syndrome 1

Interventions

venetoclax 18 Azacitidine 17 fludarabine 11 fludarabine phosphate 8 Cyclophosphamide 8 Biopsy 8 Whole-Body Irradiation 7 Specimen Handling 7 Decitabine 7 decitabine and cedazuridine drug combination 6 Injections 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 Stem Cell Transplantation 5 Melphalan 5 Cytarabine 5 Mycophenolic Acid 4 Filgrastim 4 olutasidenib 3 X-Rays 3 Thiotepa 3 Mesna 3 Cyclosporins 3 Cyclosporine 3 Cladribine 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 ruxolitinib 2 posaconazole 2 pevonedistat 2 enasidenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡